A beach chair which can be adapted for a woman who is pregnant and wishes to sunbathe in the prone position.
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 7489561 | Implantable medical device with reconfigurable non-volatile program A device comprises a stimulus generator comprising an instruction processor. The stimulus generator is configured to deliver stimuli to a biological tissue. The device also comprises a non-volatile memory for storing instructions directly executable by the instructi... | 02/10/2009 |
| 7368129 | Amphiphilic materials and liposome formulations thereof Disclosed is a new structural class of amphiphilic molecules which incorporate a hydrophilic material or polymer attached, at spatially distinct sites, to at least two hydrophobic residues. Certain of the amphiphilic molecules comprise a plurality of hydrophobic moi... | 05/06/2008 |
| 7103439 | Method and apparatus for initializing tool controllers based on tool event data A method for initializing process controllers based on tool event data includes providing a tool having a process controller adapted to employ a control model to control an operating recipe of the tool; receiving a tool event notification; and initializing the contr... | 09/05/2006 |
| 7012293 | Fabricating an SRAM cell The present invention provides an improved SRAM cell design. The SRAM cell includes a first active area on oxide in a first conductive well located on a first vertical side of the SRAM cell, a second active area on oxide in a second conductive well located on the fi... | 03/14/2006 |
| 6887468 | Antibody kits for selectively inhibiting VEGF Disclosed are antibodies that specifically inhibit VEGF binding to only one (VEGFR2) of the two VEGF receptors. The antibodies effectively inhibit angiogenesis and induce tumor regression, and yet have improved safety due to their specificity. The present invention ... | 05/03/2005 |
| 6818213 | Cancer treatment compositions comprising therapeutic conjugates that bind to aminophospholipids Disclosed is the surprising discovery that aminophospholipids, such as phosphatidylserine and phosphatidylethanolamine, are specific, accessible and stable markers of the luminal surface of tumor blood vessels. The present invention thus provides aminophospholipid-t... | 11/16/2004 |
| 6774105 | Methods of using latent TGF-β binding proteins Disclosed are novel nucleic acid and peptide compositions comprising latent TGFβ binding proteins (LTBPs). Also disclosed are methods of using LTBP-2 and LTBP-3 peptides and the DNA segments which encode them. ... | 08/10/2004 |
| 6770712 | Polyethylene/low molecular weight hydrogenated aliphatic resin blends Compositions and methods are described herein for use in packaging having improved moisture vapor barrier properties. In certain embodiments of the present invention, packaging articles can be made having improved oxygen barrier properties as well. Compositions of t... | 08/03/2004 |
| 6770740 | Crosslinked DNA condesate compositions and gene delivery methods Disclosed are improved compositions and methods for use in gene delivery and expression. A range of surprisingly effective cross-linking agents and peptides are provided, as are peptide-DNA carrier compositions and condensed particles with reduced toxicity and incre... | 08/03/2004 |
| 6767928 | Mineralization and biological modification of biomaterial surfaces Disclosed are advantageous methods for patterning and/or mineralizing biomaterial surfaces. The techniques described are particularly useful for generating three-dimensional or contoured bioimplant materials with patterned surfaces or patterned, mineralized surfaces... | 07/27/2004 |
| 6765089 | Protecting and linking groups for organic synthesis on solid supports This invention relates to methods for synthesis of organic compounds, and in particular to compounds useful as protecting and linking groups for use in the synthesis of peptides, oligosaccharides, glycopeptides and glycolipids. The invention provides protecting and ... | 07/20/2004 |
| 6755857 | Polymer heart valve with perforated stent and sewing cuff A prosthetic heart valve having an elastomeric stent with an annular base and a plurality of apertures or holes circumferentially spaced around the base for receiving a suture. Flexible polymeric leaflets are molded over the stent. Polymeric material surrounds the a... | 06/29/2004 |
| 6749853 | Combined methods and compositions for coagulation and tumor treatment Disclosed are various compositions and methods for use in achieving specific blood coagulation. This is exemplified by the specific in vivo coagulation of tumor vasculature, causing tumor regression, through the site-specific delivery of a coagulant using a bispecif... | 06/15/2004 |
| 6737536 | Inositolphospholipids and analogues This invention relates to inositolphospholipids, particularly to synthetic phosphatidyl-myo-inositols (PtdIns), ceramide-phosphoinositols (CerPhosIns) and their structural and stereochemical analogues. The invention specifically provides a novel approach to synthesi... | 05/18/2004 |
| 6723843 | Oligosaccharide synthesis The invention provides a system for solid-phase synthesis of oligosaccharides, based on the discovery that a 2-substituted-1,3-dioxocycloalkyl linker group of general formula (I) can be used to couple saccharide groups of both the O-glycoside and N-glycoside type to... | 04/20/2004 |
| 6719969 | Treatment of liver disease and injury with CXC chemokines Disclosed is the surprising discovery that CXC chemokines function to induce rapid hepatocyte proliferation and liver regeneration after injury. The invention thus provides a range of compositions and methods for use in treating liver injury, including those suitabl... | 04/13/2004 |
| 6713062 | Acinetobacter outer membrane protein and gene sequence compositions and methods Disclosed are new outer membrane proteins and nucleic acids from Acinetobacter and related biological compositions and methods. The biological materials provided are useful in diagnostic, immunological and therapeutic applications, particularly those connected with ... | 03/30/2004 |
| 6703050 | Methods and compositions for the prevention or treatment of cancer Provided are agents that can bind to copper, and form a tripartite complex with protein, and the use of these agents in the prevention and treatment of diseases with a vascular component, such as solid tumors. Compositions and methods for combination ther... | 03/09/2004 |
| 6703020 | Antibody conjugate methods for selectively inhibiting VEGF Disclosed are antibodies that specifically inhibit VEGF binding to only one (VEGFR2) of the two VEGF receptors. The antibodies effectively inhibit angiogenesis and induce tumor regression, and yet have improved safety due to their specificity. The present... | 03/09/2004 |
| 6699499 | Amphiphilic materials and liposome formulations thereof Disclosed is a new structural class of amphiphilic molecules which incorporate a hydrophilic material or polymer attached, at spatially distinct sites, to at least two hydrophobic residues. Certain of the amphiphilic molecules comprise a plurality of hydr... | 03/02/2004 |
| 6676941 | Antibody conjugate formulations for selectively inhibiting VEGF Disclosed are antibodies that specifically inhibit VEGF binding to only one (VEGFR2) of the two VEGF receptors. The antibodies effectively inhibit angiogenesis and induce tumor regression, and yet have improved safety due to their specificity. The present... | 01/13/2004 |
| 6660750 | Flavopiridol methods and compositions for HIV therapy Disclosed is the unexpected discovery that flavopiridol binds tightly to the transcription elongation factor, P-TEFb and dramatically inhibits its activity. As P-TEFb is required for HIV propagation and replication, this invention provides new methods, co... | 12/09/2003 |
| 6648097 | Seismic methods having extended energy release An improved seismic method comprises the steps of generating seismic waves by exploding an explosive device in a subterranean formation, wherein the explosive device comprises a plurality of explosive elements whereby there is a time delay between the det... | 11/18/2003 |
| 6641734 | Process for purifying an organic acid A process is disclosed for purifying an aqueous feed stream comprising a product organic acid, such as lactic acid, and a strong contaminant, such as pyruvic acid or oxalic acid. The molar concentration of the product organic acid in the feed stream typic... | 11/04/2003 |
| 6642324 | Process that produces polymers A process comprising polymerizing ethylene, or polymerizing ethylene and at least one other olefin, to produce a polymer is provided.... | 11/04/2003 |
| 6632806 | Neurologically-active compounds The invention provides methods for enhancing cognitive activity and stimulating memory capacity, comprising the step of administering an effective amount of a compound with GABAC receptor antagonist activity to an animal in need of such treatme... | 10/14/2003 |
| 6624141 | Protamine fragment compositions and methods of use Provided are bioactive, low-toxicity protamine fragments, compositions, combinations, kits and methods of using these components in a variety of embodiments, including neutralizing heparin and reducing post-operative bleeding. Improved protamine fragment-... | 09/23/2003 |
| 6610215 | Oxygen scavenging compositions suitable for heat triggering Methods of initiating oxygen scavenging are disclosed herein that rely on heat triggering. An oxygen scavenging composition that comprises an oxidizable organic compound and a transition metal catalyst is heated to an extent sufficient to initiate oxygen ... | 08/26/2003 |
| 6591998 | Leakproof container for implantable prosthetic device A packaging for an implantable medical device such as a heart valve wherein the implantable medical device is immersed in a liquid medium. The packaging comprises a jar and a lid assembly having a seal and a ridge therebetween, the ridge being adapted to ... | 07/15/2003 |
| 6583241 | Process for making MVTR resin The present invention is directed to producing a resin which, when formed into a film, has excellent gas barrier and/or moisture barrier (low MVTR) properties. Further, the resin has a relatively high molecular weight distribution, preferably above 6, and... | 06/24/2003 |
| 6573337 | Oligosaccharide synthesis The invention provides a system for solid-phase synthesis of oligosaccharides, based on the discovery that a 2-substituted-1,3-dioxocycloalkyl linker group of general formula (I) can be used to couple saccharide groups of both the O-glycoside and N-g... | 06/03/2003 |
| 6541022 | Mineral and cellular patterning on biomaterial surfaces Disclosed are advantageous methods for patterning and/or mineralizing biomaterial surfaces. The techniques described are particularly useful for generating three-dimensional or contoured bioimplant materials with patterned surfaces or patterned, mineraliz... | 04/01/2003 |
| 6531565 | MVTR resin produced with post-titanated Cr/Si/Ti catalyst A process is disclosed for producing polyethylene resin of broad molecular weight distribution, when formed into a film, high barrier to moisture (low MVTR (Moisture Vapor Transmission Rate) for the film). The resin is formed by polymerizing ethylene, pre... | 03/11/2003 |
| 6527976 | Epoxy-, melamine- and isocyanate cured oxygen scavenging compositions and methods of preparing the same An oxygen scavenging composition that can be either thermoplastic or thermoset, and that comprises at least one oxygen scavenging polymer and at least one curing agent is disclosed. The oxygen scavenging polymer comprises a polymeric backbone, at least tw... | 03/04/2003 |
| 6528088 | Highly flexible starch-based films Film-forming compositions are disclosed that can comprise, on a dry solids basis, 25 to 75 percent by weight of certain starch derivatives and 25 to 75% primary external plasticizer. The starch derivatives can be chemically modified starches that range in... | 03/04/2003 |
| 6524583 | Antibody methods for selectively inhibiting VEGF Disclosed are antibodies that specifically inhibit VEGF binding to only one (VEGFR2) of the two VEGF receptors. The antibodies effectively inhibit angiogenesis and induce tumor regression, and yet have improved safety due to their specificity. The present... | 02/25/2003 |
| 6491906 | CXC chemokines as regulators of angiogenesis Disclosed are various discoveries concerning the angiogenic and angiostatic properties of the CXC chemokines, including the finding that the ELR motif controls the ability of these molecules to induce angiogenesis. Aspects of the invention include, for ex... | 12/10/2002 |
| 6489163 | Ribozyme mediated inactivation of the androgen receptor The present invention provides synthetic ribozyme oligonucleotides alone and within constructs. The ribozyme gene provides methods for the treatment of prostate hyperplasia and other androgen dependent pathologies. Improved therapies for such diseases are... | 12/03/2002 |
| 6482411 | Methods of reducing bone loss with CD40 ligand Provided are methods and compositions using one or more CD40 agonists, such as CD40 ligands and/or agonistic anti-CD40 antibodies, to reduce or prevent cell death, or apoptosis, in bone cells. Methods of treating or preventing bone loss, including osteopo... | 11/19/2002 |
| 6479662 | Antitumor dibenzofluorene derivatives Dibenzofluorene derivatives having a formula selected from the group consisting of ##STR1## and salts thereof have antitumor activity. At least one of R1 -R13 in formula (I) or R1 -R12 in formula (II) is --... | 11/12/2002 |